Virtual Reality Distraction During Arteriovenous Fistula Puncture

Sponsor
Mansoura University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05399199
Collaborator
(none)
90
1
2
6.3
14.2

Study Details

Study Description

Brief Summary

The cannulation of arteriovenous fistula is a painful procedure in hemodialysis patients. Previous studies have shown the effectiveness of virtual reality in reducing pain during needle-related procedures

Condition or Disease Intervention/Treatment Phase
  • Procedure: virtual reality distraction
N/A

Detailed Description

Patients undergoing hemodialysis experience anxiety and pain related to the insertion of hemodialysis needles, estimated 320 times in total per year. The pain experienced is mostly caused by needle insertion into a fistula. Pain control is one of the main nursing tasks. Pain relief leads to the acceptance of the procedure and ultimately enhances the patients' quality of life. The use of virtual reality to reduce pain and anxiety during the arteriovenous fistula cannulation procedure is based on the concept that the perception of pain can be controlled because an individual is able to process only a limited amount of information at once. As such, the use of virtual reality during painful procedures may serve as a distraction.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Virtual Reality Distraction on Pain and Anxiety During Arteriovenous Fistula Puncture Among Hemodialysis Patients: Randomized Controlled Trial
Actual Study Start Date :
Jun 5, 2022
Anticipated Primary Completion Date :
Sep 15, 2022
Anticipated Study Completion Date :
Dec 15, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: study group

Procedure: virtual reality distraction
study group patients will view VR scene for 15 minutes before puncture .It involves a soothing nature experience and calming background music. Patients in intervention group will not able to see the puncture procedure due to the VR glasses.

No Intervention: control group

Outcome Measures

Primary Outcome Measures

  1. change in patients pain scores [will be measured at baseline and immediately after intervention (after 15 minutes of VR distraction)]

    visual analogue scale which consists of a vertical line 100 mm long, one end of the line reads "No pain" and at the other is "Unbearable pain

  2. change in patients anxiety scores [will be measured at baseline and immediately after intervention (after 15 minutes of VR distraction)]

    STAI includes two subscales with 20 items each that assess state and trait anxiety .The State Anxiety Scale requires individuals to describe their feelings at a specific moment under specific circumstances, while the Trait Anxiety Scale requires them to describe the way they feel in general.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients who are under- going conventional hemodialysis three times a week

  • hemodialysis period of one month or more

  • having a healthy AVF access with good function

  • welling to participate in study

Exclusion Criteria:
  • patients who have psychiatric diseases

  • panic disorder, anxiety disorder

  • dysfunctional fistula

  • vertigo, issues with sight, hearing, or perception

  • or use painkillers within three hours before hemodialysis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Nursing Mansoura University Mansoura Egypt

Sponsors and Collaborators

  • Mansoura University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
mohamed elsayed hamed elzeky, lecturer, medical surgical nursing department, faculty of nursing, Mansoura university, Mansoura University
ClinicalTrials.gov Identifier:
NCT05399199
Other Study ID Numbers:
  • mansU
First Posted:
Jun 1, 2022
Last Update Posted:
Jun 8, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 8, 2022